Cambridge Investment Research Advisors Inc. purchased a new position in MarineMax, Inc. (NYSE:HZO – Get Rating) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 8,357 shares of the specialty retailer’s stock, valued at approximately $249,000.
A number of other institutional investors also recently made changes to their positions in the stock. Amundi raised its holdings in shares of MarineMax by 74.7% in the second quarter. Amundi now owns 1,385 shares of the specialty retailer’s stock worth $53,000 after acquiring an additional 592 shares during the last quarter. Captrust Financial Advisors increased its stake in MarineMax by 9.6% in the second quarter. Captrust Financial Advisors now owns 2,911 shares of the specialty retailer’s stock valued at $105,000 after purchasing an additional 255 shares during the last quarter. ExodusPoint Capital Management LP acquired a new position in MarineMax in the second quarter valued at $2,441,000. Goldman Sachs Group Inc. increased its stake in MarineMax by 20.9% in the second quarter. Goldman Sachs Group Inc. now owns 174,200 shares of the specialty retailer’s stock valued at $6,293,000 after purchasing an additional 30,151 shares during the last quarter. Finally, Thrivent Financial for Lutherans increased its stake in MarineMax by 18.5% in the second quarter. Thrivent Financial for Lutherans now owns 21,154 shares of the specialty retailer’s stock valued at $764,000 after purchasing an additional 3,310 shares during the last quarter. 95.93% of the stock is owned by institutional investors and hedge funds.
MarineMax Price Performance
Shares of NYSE HZO opened at $34.47 on Friday. MarineMax, Inc. has a 1-year low of $27.40 and a 1-year high of $52.55. The business has a 50-day moving average of $32.26 and a 200-day moving average of $34.34. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.83 and a quick ratio of 0.73. The company has a market capitalization of $753.17 million, a price-to-earnings ratio of 3.89 and a beta of 1.58.
Wall Street Analysts Forecast Growth
Several research firms recently commented on HZO. Citigroup dropped their target price on MarineMax from $43.00 to $39.00 in a research note on Friday, October 28th. B. Riley boosted their price target on MarineMax from $32.00 to $35.00 in a research report on Friday, October 28th. Truist Financial lowered their price target on MarineMax from $50.00 to $45.00 and set a “buy” rating for the company in a research report on Wednesday, October 5th. Stifel Nicolaus began coverage on MarineMax in a research report on Wednesday, December 14th. They set a “buy” rating and a $40.00 price target for the company. Finally, Raymond James lowered their price target on MarineMax from $66.00 to $55.00 and set an “outperform” rating for the company in a research report on Friday, October 28th. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $43.00.
MarineMax, Inc operates as a recreational boat and yacht retailer and superyacht services company in the United States. It operates in two segments, Retail Operations and Product Manufacturing. The company sells new and used recreational boats, including pleasure and fishing boats, mega-yachts, yachts, sport cruisers, motor yachts, e-power yachts, pontoon boats, ski boats, jet boats, and other recreational boats.
- Get a free copy of the StockNews.com research report on MarineMax (HZO)
- MarketBeat: Week in Review 01/09-01/13
- JPMorgan Chase Falls As Banks Brace For Recession
- Why is the Bed Bath & Beyond Stock Price up 261%?
- Roku Stock Price is Trending, Here’s Why
- Carvana Stock Rally, Here’s What You Need to Know
Receive News & Ratings for MarineMax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MarineMax and related companies with MarketBeat.com's FREE daily email newsletter.